Evidence map›Paper›PMID 29540175›Full record

ArticleLipids in health and disease2018

Complex genetic architecture in severe hypobetalipoproteinemia.

Linda R Wang, Adam D McIntyre, Robert A Hegele

Open access · goldAbstract readCase Reports
In one paragraph

Article in Lipids in health and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. A Rare Mutation in TheInternational journal of molecular sciences · 2020
    Article
  6. Article
  7. Severe Combined Dyslipidemia With a Complex Genetic Basis.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Linda R WangDepartment of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, 4288A - 1151 Richmond Street North, London, ON, N6A 5B7, Canada.
Adam D McIntyreDepartment of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, 4288A - 1151 Richmond Street North, London, ON, N6A 5B7, Canada.
Robert A HegeleDepartment of Medicine and Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, 4288A - 1151 Richmond Street North, London, ON, N6A 5B7, Canada. hegele@robarts.ca.
Western University · CA

Funding

Canadian Insitutes of Health Research Foundation awardGenome Canada 4530Heart and Stroke Foundation of Canada T-000353
6 · The paper itself

Abstract

backgroundAbetalipoproteinemia and homozygous hypobetalipoproteinemia are classical Mendelian autosomal recessive and co-dominant conditions, respectively, which are phenotypically similar and are usually caused by bi-allelic mutations in MTTP and APOB genes, respectively. Instances of more complex patterns of genomic variants resulting in this distinct phenotype have not been reported.

methodsA 43 year-old male had a longstanding severe deficiency of apolipoprotein (apo) B-containing lipoproteins and circulating fat soluble vitamins consistent with either abetalipoproteinemia or homozygous familial hypobetalipoproteinemia (FHBL). He also had acanthocytosis, a long term history of fat malabsorption, and mild retinopathy, but was free from coagulopathy, myopathy and neuropathy. He had taken high dose oral fat soluble vitamins since childhood.

resultsTargeted next generation DNA sequencing revealed several rare heterozygous missense variants in both MTTP and APOB genes known or predicted to be deleterious, in addition to a novel heterozygous missense variant in SAR1B, which encodes the gene causing chylomicron retention disease. Evaluation of first degree relatives with mild FHBL clarified the segregation of variants.

conclusionsThe proband's characteristic phenotype likely resulted from an oligogenic interaction involving multiple rare variants in MTTP and APOB, and related genes, each of which individually was associated with a milder or minimal clinical and biochemical phenotype.

Indexed as

AdultApolipoprotein B-100Carrier ProteinsGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHomozygoteHumansHypobetalipoproteinemiasMaleMonomeric GTP-Binding ProteinsMutation, MissenseAPOB protein, humanApolipoprotein B-100Carrier Proteinsmicrosomal triglyceride transfer proteinMonomeric GTP-Binding ProteinsSAR1B protein, humanAbetalipoproteinemiaAcanthocytosisComplex traitDNA mutationsDNA sequencingHypobetalipoproteinemiaOligogenic trait

Identifiers

PMID29540175
PMCPMC5853080
OpenAlexW2799416499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.